2012 - NANETS https://nanets.net/abstracts-archive/2012?format=html Thu, 15 Feb 2018 12:54:23 -0500 en-GB hourly 1 O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome https://nanets.net/abstracts-archive/2012/223-o01-an-ongoing-double-blind-randomized-placebo-controlled-clinical-trial-investigating-the-efficacy-and-safety-of-somatuline-depot-lanreotide-injection-in-the-treatment-of-carcinoid-syndrome?format=html O01 – An Ongoing, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline® Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome Edda Gomez-Panzani, Veronique Fohanno

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/223-o01-an-ongoing-double-blind-randomized-placebo-controlled-clinical-trial-investigating-the-efficacy-and-safety-of-somatuline-depot-lanreotide-injection-in-the-treatment-of-carcinoid-syndrome?format=html Edda Gomez-Panzani, Veronique Fohanno

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:54:23 -0500 C53 – Baseline Demographics of Neuroendocrine Tumor Patients Presenting to Seven National Comprehensive Cancer Network (NCCN) Institutions: Development of a Multi-Institutional Outcomes Database https://nanets.net/abstracts-archive/2012/222-c53-baseline-demographics-of-neuroendocrine-tumor-patients-presenting-to-seven-national-comprehensive-cancer-network-nccn-institutions-development-of-a-multi-institutional-outcomes-database?format=html C53 – Baseline Demographics of Neuroendocrine Tumor Patients Presenting to Seven National Comprehensive Cancer Network (NCCN) Institutions: Development of a Multi-Institutional Outcomes Database Carrie C. Zornosa, MSPH; Michael A. Choti, MD; Sarah Bobiak, PhD; Matthew H. Kulke, MD; James C. Yao, MD; Emily K. Bergsland, MD; Eric K. Nakakura, MD; P. Mark Bloomston, MD; Al B. Benson, III, MD; Manisha H. Shah, MD; Jonathan R. Strosberg, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/222-c53-baseline-demographics-of-neuroendocrine-tumor-patients-presenting-to-seven-national-comprehensive-cancer-network-nccn-institutions-development-of-a-multi-institutional-outcomes-database?format=html Carrie C. Zornosa, MSPH; Michael A. Choti, MD; Sarah Bobiak, PhD; Matthew H. Kulke, MD; James C. Yao, MD; Emily K. Bergsland, MD; Eric K. Nakakura, MD; P. Mark Bloomston, MD; Al B. Benson, III, MD; Manisha H. Shah, MD; Jonathan R. Strosberg, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:34 -0500 C52 – Is There a Role for Radiation for Neuroendocrine Neoplasm Hepatic Metastases? https://nanets.net/abstracts-archive/2012/221-c52-is-there-a-role-for-radiation-for-neuroendocrine-neoplasm-hepatic-metastases?format=html C52 – Is There a Role for Radiation for Neuroendocrine Neoplasm Hepatic Metastases? Rebecca Zener, MD; Michael Lock, MD; Walter Kocha, MD; Robert Reid, MD; Daryl Gray, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/221-c52-is-there-a-role-for-radiation-for-neuroendocrine-neoplasm-hepatic-metastases?format=html Rebecca Zener, MD; Michael Lock, MD; Walter Kocha, MD; Robert Reid, MD; Daryl Gray, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:33 -0500 C51 – The VEGF Pathway in Pancreatic Neuroendocrine Tumors: Prognostic and Predictive Capacity of Baseline Biomarker Levels on Efficacy of Everolimus Analyzed From the RADIANT-3 Study https://nanets.net/abstracts-archive/2012/220-c51-the-vegf-pathway-in-pancreatic-neuroendocrine-tumors-prognostic-and-predictive-capacity-of-baseline-biomarker-levels-on-efficacy-of-everolimus-analyzed-from-the-radiant-3-study?format=html C51 – The VEGF Pathway in Pancreatic Neuroendocrine Tumors: Prognostic and Predictive Capacity of Baseline Biomarker Levels on Efficacy of Everolimus Analyzed From the RADIANT-3 Study James C. Yao; Manisha Shah; Ashok Panneerselvam; David Chen; Sotirios Stergiopoulos; Tetsuhide Ito; Marianne Pavel

]]> https://nanets.net/abstracts-archive/2012/220-c51-the-vegf-pathway-in-pancreatic-neuroendocrine-tumors-prognostic-and-predictive-capacity-of-baseline-biomarker-levels-on-efficacy-of-everolimus-analyzed-from-the-radiant-3-study?format=html James C. Yao; Manisha Shah; Ashok Panneerselvam; David Chen; Sotirios Stergiopoulos; Tetsuhide Ito; Marianne Pavel

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:32 -0500 C50 – RADIANT-4: A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus Versus Placebo in the Treatment of Patients With Advanced Non-functional NET of GI or Lung Origin https://nanets.net/abstracts-archive/2012/219-c50-radiant-4-a-randomized-double-blind-multicenter-phase-iii-study-of-everolimus-versus-placebo-in-the-treatment-of-patients-with-advanced-non-functional-net-of-gi-or-lung-origin?format=html C50 – RADIANT-4: A Randomized, Double-blind, Multicenter, Phase III Study of Everolimus Versus Placebo in the Treatment of Patients With Advanced Non-functional NET of GI or Lung Origin James C Yao; Marianne E Pavel; Nicola Fazio; Matthew Kulke; Simron Singh; Gaurav Shah; Judith Klimovsky; Jonathan Strosberg

]]> https://nanets.net/abstracts-archive/2012/219-c50-radiant-4-a-randomized-double-blind-multicenter-phase-iii-study-of-everolimus-versus-placebo-in-the-treatment-of-patients-with-advanced-non-functional-net-of-gi-or-lung-origin?format=html James C Yao; Marianne E Pavel; Nicola Fazio; Matthew Kulke; Simron Singh; Gaurav Shah; Judith Klimovsky; Jonathan Strosberg

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:31 -0500 C48 – Comparison of Yttirum-90 Microspheres and Transarterial Chemoembolization in the Treatment of Inoperable Metastatic Neuroendocrine Tumors https://nanets.net/abstracts-archive/2012/217-c48-comparison-of-yttirum-90-microspheres-and-transarterial-chemoembolization-in-the-treatment-of-inoperable-metastatic-neuroendocrine-tumors?format=html C48 – Comparison of Yttirum-90 Microspheres and Transarterial Chemoembolization in the Treatment of Inoperable Metastatic Neuroendocrine Tumors Yuhsin V. Wu MD; Garin Tomaszewski MD; Adrienne E. Groman MS; Renuka V. Iyer MD; Boris W. Kuvshinoff MD, MBA

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/217-c48-comparison-of-yttirum-90-microspheres-and-transarterial-chemoembolization-in-the-treatment-of-inoperable-metastatic-neuroendocrine-tumors?format=html Yuhsin V. Wu MD; Garin Tomaszewski MD; Adrienne E. Groman MS; Renuka V. Iyer MD; Boris W. Kuvshinoff MD, MBA

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:30 -0500 C49 – Dosing Patterns of Octreotide LAR Among Elderly Patients with Neuroendocrine Tumors: Analysis of the SEER-Medicare Database https://nanets.net/abstracts-archive/2012/218-c49-dosing-patterns-of-octreotide-lar-among-elderly-patients-with-neuroendocrine-tumors-analysis-of-the-seer-medicare-database?format=html C49 – Dosing Patterns of Octreotide LAR Among Elderly Patients with Neuroendocrine Tumors: Analysis of the SEER-Medicare Database Ying Xu; Ya-Chen Tina Shih; Colleen C. Leary; Chan Shen; James C. Yao

]]> https://nanets.net/abstracts-archive/2012/218-c49-dosing-patterns-of-octreotide-lar-among-elderly-patients-with-neuroendocrine-tumors-analysis-of-the-seer-medicare-database?format=html Ying Xu; Ya-Chen Tina Shih; Colleen C. Leary; Chan Shen; James C. Yao

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:30 -0500 C47 – Effect of Open-Label Everolimus in Patients With Advanced Neuroendocrine Tumors After Disease Progression on Somatostatin Analog: A RADIANT-2 Analysis https://nanets.net/abstracts-archive/2012/216-c47-effect-of-open-label-everolimus-in-patients-with-advanced-neuroendocrine-tumors-after-disease-progression-on-somatostatin-analog-a-radiant-2-analysis?format=html C47 – Effect of Open-Label Everolimus in Patients With Advanced Neuroendocrine Tumors After Disease Progression on Somatostatin Analog: A RADIANT-2 Analysis Edward M. Wolin; John D. Hainsworth; Dieter HÖrsch; Gabriele Luppi; Valentine Jehl; Marc Peeters

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/216-c47-effect-of-open-label-everolimus-in-patients-with-advanced-neuroendocrine-tumors-after-disease-progression-on-somatostatin-analog-a-radiant-2-analysis?format=html Edward M. Wolin; John D. Hainsworth; Dieter HÖrsch; Gabriele Luppi; Valentine Jehl; Marc Peeters

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:29 -0500 C46 – Above-Label Doses of Octreotide-LAR in Patients with Metastatic Small Intestinal Carcinoid Tumors https://nanets.net/abstracts-archive/2012/215-c46-above-label-doses-of-octreotide-lar-in-patients-with-metastatic-small-intestinal-carcinoid-tumors?format=html C46 – Above-Label Doses of Octreotide-LAR in Patients with Metastatic Small Intestinal Carcinoid Tumors Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD; Jonathan Strosberg, MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/215-c46-above-label-doses-of-octreotide-lar-in-patients-with-metastatic-small-intestinal-carcinoid-tumors?format=html Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD; Jonathan Strosberg, MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:28 -0500 C45 – Surgical Treatment Options for Rectal Carcinoid Cancer: Trans-Anal Excision versus Low Anterior Resection with Total Mesorectal Excision https://nanets.net/abstracts-archive/2012/214-c45-surgical-treatment-options-for-rectal-carcinoid-cancer-trans-anal-excision-versus-low-anterior-resection-with-total-mesorectal-excision?format=html C45 – Surgical Treatment Options for Rectal Carcinoid Cancer: Trans-Anal Excision versus Low Anterior Resection with Total Mesorectal Excision Yi-Zarn Wang DDS, MD; Anne Diebold BS; Philip Boudreaux MD; Daniel Raines MD; Richard Campeau MD; Lowell Anthony MD; Eugene Woltering MD

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/214-c45-surgical-treatment-options-for-rectal-carcinoid-cancer-trans-anal-excision-versus-low-anterior-resection-with-total-mesorectal-excision?format=html Yi-Zarn Wang DDS, MD; Anne Diebold BS; Philip Boudreaux MD; Daniel Raines MD; Richard Campeau MD; Lowell Anthony MD; Eugene Woltering MD

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:27 -0500 C43 – The Changing Presentation of Pancreatic Neuroendocrine Tumors: Results of 344 Resected Patients over 30 years https://nanets.net/abstracts-archive/2012/212-c43-the-changing-presentation-of-pancreatic-neuroendocrine-tumors-results-of-344-resected-patients-over-30-years?format=html C43 – The Changing Presentation of Pancreatic Neuroendocrine Tumors: Results of 344 Resected Patients over 30 years Brian R. Untch; Diane L. Reidy-Lagunes; Laura H. Tang; Murray F. Brennan; William R. Jarnagin; Peter J. Allen

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/212-c43-the-changing-presentation-of-pancreatic-neuroendocrine-tumors-results-of-344-resected-patients-over-30-years?format=html Brian R. Untch; Diane L. Reidy-Lagunes; Laura H. Tang; Murray F. Brennan; William R. Jarnagin; Peter J. Allen

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:26 -0500 C44 – Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumor- Total Mesorectal Excision May be Insufficient for Some Rectal Carcinoids https://nanets.net/abstracts-archive/2012/213-c44-obturator-canal-lymph-node-metastasis-from-rectal-carcinoid-tumor-total-mesorectal-excision-may-be-insufficient-for-some-rectal-carcinoids?format=html C44 – Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumor- Total Mesorectal Excision May be Insufficient for Some Rectal Carcinoids Yi-Zarn Wang DDS, MD; Michael Hall MD, MS

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/213-c44-obturator-canal-lymph-node-metastasis-from-rectal-carcinoid-tumor-total-mesorectal-excision-may-be-insufficient-for-some-rectal-carcinoids?format=html Yi-Zarn Wang DDS, MD; Michael Hall MD, MS

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:26 -0500 C42 – Diagnostic Performance of Dual Tracer PET/CT in Staging Neuroendocrine Tumors of the Lung https://nanets.net/abstracts-archive/2012/211-c42-diagnostic-performance-of-dual-tracer-pet-ct-in-staging-neuroendocrine-tumors-of-the-lung?format=html C42 – Diagnostic Performance of Dual Tracer PET/CT in Staging Neuroendocrine Tumors of the Lung Giorgio Treglia; Antonella Stefanelli; Giuseppe Cardillo; Filippo Lococo; Guido Rindi; Vittoria Rufini

]]> https://nanets.net/abstracts-archive/2012/211-c42-diagnostic-performance-of-dual-tracer-pet-ct-in-staging-neuroendocrine-tumors-of-the-lung?format=html Giorgio Treglia; Antonella Stefanelli; Giuseppe Cardillo; Filippo Lococo; Guido Rindi; Vittoria Rufini

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:25 -0500 C41 – Duration and Type of Presenting Symptoms in Patients with Neuroendocrine Tumor (NET) https://nanets.net/abstracts-archive/2012/210-c41-duration-and-type-of-presenting-symptoms-in-patients-with-neuroendocrine-tumor-net?format=html C41 – Duration and Type of Presenting Symptoms in Patients with Neuroendocrine Tumor (NET) Monica Ter-Minassian; Jennifer A. Chan; Susanne M. Hooshmand; Lauren K. Brais; Anastassia Daskalova; Rachel Heafield; Laurie Buchanan; Zhi Rong Qian; Xihong Lin ;David C. Christiani; Matthew H. Kulke

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/210-c41-duration-and-type-of-presenting-symptoms-in-patients-with-neuroendocrine-tumor-net?format=html Monica Ter-Minassian; Jennifer A. Chan; Susanne M. Hooshmand; Lauren K. Brais; Anastassia Daskalova; Rachel Heafield; Laurie Buchanan; Zhi Rong Qian; Xihong Lin ;David C. Christiani; Matthew H. Kulke

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:24 -0500 C40 – Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series https://nanets.net/abstracts-archive/2012/209-c40-treatment-of-metastatic-neuroendocrine-tumors-of-the-thymus-with-capecitabine-and-temozolomide-a-case-series?format=html C40 – Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series Jonathan Strosberg, MD; Vita Saranga-Perry, MD; Brian Morse, MD; Barbara Centeno, MD; Larry Kvols MD

]]> https://nanets.net/abstracts-archive/2012/209-c40-treatment-of-metastatic-neuroendocrine-tumors-of-the-thymus-with-capecitabine-and-temozolomide-a-case-series?format=html Jonathan Strosberg, MD; Vita Saranga-Perry, MD; Brian Morse, MD; Barbara Centeno, MD; Larry Kvols MD

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:23 -0500 C39 – Prognostic Validity of the American Joint Committee on Cancer (AJCC) Staging Classification for Midgut Neuroendocrine Tumors https://nanets.net/abstracts-archive/2012/208-c39-prognostic-validity-of-the-american-joint-committee-on-cancer-ajcc-staging-classification-for-midgut-neuroendocrine-tumors?format=html C39 – Prognostic Validity of the American Joint Committee on Cancer (AJCC) Staging Classification for Midgut Neuroendocrine Tumors Jonathan Strosberg, MD; Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD

]]> https://nanets.net/abstracts-archive/2012/208-c39-prognostic-validity-of-the-american-joint-committee-on-cancer-ajcc-staging-classification-for-midgut-neuroendocrine-tumors?format=html Jonathan Strosberg, MD; Jill Weber, MPH; Max Feldman, MD; Larry Kvols, MD

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:22 -0500 C38 – Expert Panel Consensus Statements on the Medical Treatment of Unresectable Midgut Gastrointestinal Neuroendocrine Tumors https://nanets.net/abstracts-archive/2012/207-c38-expert-panel-consensus-statements-on-the-medical-treatment-of-unresectable-midgut-gastrointestinal-neuroendocrine-tumors?format=html C38 – Expert Panel Consensus Statements on the Medical Treatment of Unresectable Midgut Gastrointestinal Neuroendocrine Tumors Jonathan R. Strosberg; George A. Fisher; Al B. Benson; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples; Philip A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/207-c38-expert-panel-consensus-statements-on-the-medical-treatment-of-unresectable-midgut-gastrointestinal-neuroendocrine-tumors?format=html Jonathan R. Strosberg; George A. Fisher; Al B. Benson; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples; Philip A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:21 -0500 C37 – Does the ENETS TNM staging criteria predict survival in patients with small bowel neuroendocrine tumours? https://nanets.net/abstracts-archive/2012/206-c37-does-the-enets-tnm-staging-criteria-predict-survival-in-patients-with-small-bowel-neuroendocrine-tumours?format=html C37 – Does the ENETS TNM staging criteria predict survival in patients with small bowel neuroendocrine tumours? Rajaventhan Srirajaskanthan; Adil Ahmed; John K. Ramage

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/206-c37-does-the-enets-tnm-staging-criteria-predict-survival-in-patients-with-small-bowel-neuroendocrine-tumours?format=html Rajaventhan Srirajaskanthan; Adil Ahmed; John K. Ramage

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:20 -0500 C35 – Review of 126 High Grade Neuro-Endocrine Carcinomas of the Colon and Rectum https://nanets.net/abstracts-archive/2012/204-c35-review-of-126-high-grade-neuro-endocrine-carcinomas-of-the-colon-and-rectum?format=html C35 – Review of 126 High Grade Neuro-Endocrine Carcinomas of the Colon and Rectum James D. Smith; Diane L. Reidy; Martin Weiser; Larissa K. Temple; Jose G. Guillem; Philip B. Paty; Garrett M. Nash

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/204-c35-review-of-126-high-grade-neuro-endocrine-carcinomas-of-the-colon-and-rectum?format=html James D. Smith; Diane L. Reidy; Martin Weiser; Larissa K. Temple; Jose G. Guillem; Philip B. Paty; Garrett M. Nash

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:19 -0500 C36 – Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3) https://nanets.net/abstracts-archive/2012/205-c36-ki-67-proliferative-index-predicts-response-to-chemotherapy-and-survival-in-252-patients-with-high-grade-gastrointestinal-neuroendocrine-carcinoma-who-g3?format=html C36 – Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3) Halfdan Sorbye; Staffan Welin; Seppo Langer; Lena Vestermark; Nanna Holt; Pia Osterlund; Svein, Dueland; Eva Hofsli; Marianne Guren; Katarina Ohrling; Elke Birkemeyer; Espen Thiis-Evensen; Matteo Biagini; Henning Gronbaek; Leena-Maija Soveri; Ingrid Holst Olsen; Birgitte Federspiel; Jurg Assmus; Eva Tiensuu Janson; Ulrich Knigge

 Download Poster

]]> https://nanets.net/abstracts-archive/2012/205-c36-ki-67-proliferative-index-predicts-response-to-chemotherapy-and-survival-in-252-patients-with-high-grade-gastrointestinal-neuroendocrine-carcinoma-who-g3?format=html Halfdan Sorbye; Staffan Welin; Seppo Langer; Lena Vestermark; Nanna Holt; Pia Osterlund; Svein, Dueland; Eva Hofsli; Marianne Guren; Katarina Ohrling; Elke Birkemeyer; Espen Thiis-Evensen; Matteo Biagini; Henning Gronbaek; Leena-Maija Soveri; Ingrid Holst Olsen; Birgitte Federspiel; Jurg Assmus; Eva Tiensuu Janson; Ulrich Knigge

 Download Poster

]]> support@adgcommunications.com (Super User) 2012 Thu, 15 Feb 2018 12:53:19 -0500